# Who can be considered for weight-management medication?

BMI is one part of eligibility. Weight-related conditions, medical history, medicines and the specific product also shape the decision.

Canonical: https://velri.co/blog/glp1-only-for-very-overweight-myth-provider-reads-bmi-waist-metabolic-markers
Publisher: Velri (https://velri.co/about)
Published: 2026-07-25
Updated: 2026-09-30
Editorial policy: https://velri.co/editorial-policy

A very high BMI is not the only situation in which weight-management medication may be considered. NIDDK describes common adult criteria as a BMI of 30 or higher, or 27 or higher with a weight-related health condition, such as high blood pressure or type 2 diabetes. [1]

Meeting those criteria starts an assessment. It does not establish that a particular medication is appropriate.

## BMI answers a limited question

BMI relates weight to height. It is used in many treatment criteria, but it is only one part of a person's health assessment. NIDDK also identifies current health conditions, other medicines, family medical history, possible side effects and likely benefits as factors in choosing medication. [1]

## The product and intended use matter

Different medications have different approved uses and restrictions. The approved semaglutide weight-management label includes adults with obesity and adults with overweight who have at least one weight-related condition. It also sets out contraindications and precautions that must be considered separately. [2]

A blood test or waist measurement may help characterize health risk. Neither should be treated as a shortcut around the requirements and safety review for the actual product being considered.

## The discussion should include the longer term

Weight-management medicines are used alongside eating and physical-activity changes. Follow-up considers response, tolerability and whether continuing treatment remains appropriate. Cost and the ability to maintain care are also relevant to the choice. [1]

For a first conversation, bring a current medication list, relevant diagnoses and a brief history of prior weight-management approaches. Describe what you want help with in concrete terms, such as managing a weight-related condition or improving an activity affected by weight.

## Sources
[1] Prescription Medications to Treat Overweight & Obesity - NIDDK. https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity
[2] DailyMed - WEGOVY- semaglutide injection, solution
WEGOVY- semaglutide tablet. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b

## About this information
General health information, not personal medical advice, diagnosis or treatment. A prescription is required and is never guaranteed.
Velri is a brand operated by Velri Management LLC, a Nevada limited liability company. Velri is a non-clinical technology and administrative services company. Velri does not provide medical advice, diagnosis, treatment, or pharmacy services, and does not direct the clinical judgment of any provider.
All medical consultations and prescriptions are provided directly by independent provider groups (Online Medical Care, P.C.; TMD of Kansas, P.A.; TMD of Texas, P.A.; and TMD of CA, PC), by a provider licensed in your state. Velri does not employ providers. A prescription is issued only if a provider determines it is clinically appropriate in their independent medical judgment.
All prescription products are dispensed by independent, licensed pharmacies. Velri does not own, operate, or control any pharmacy and does not dispense medication. You may opt out of using a given provider group or pharmacy at any time.
Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
Velri is cash-pay. We do not bill Medicare, Medicaid, or commercial insurance. Refunds and order problems are addressed in the Terms of Use; your rights under applicable law are not limited. State availability and clinical eligibility apply.
Velri and telehealth are not for medical emergencies. If you are experiencing an emergency, call 911.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Care is available to eligible adults 18 and older in 47 states and D.C., United States only.
Notice of Privacy Practices: https://velri.co/privacy/notice-of-privacy-practices
Terms: https://velri.co/legal/terms
Provider group or pharmacy opt-out help: https://velri.co/contact and https://velri.co/standards#trust-support